Infection Surveillance Solution Market Overview
As per MRFR analysis, the Infection Surveillance Solution Market Size was estimated at 0.73 (USD Billion) in 2023.The Infection Surveillance Solution Market Industry is expected to grow from 0.80(USD Billion) in 2024 to 1.64 (USD Billion) by 2032. The Infection Surveillance Solution Market CAGR (growth rate) is expected to be around 9.44% during the forecast period (2024 - 2032).
Key Infection Surveillance Solution Market Trends Highlighted
Most Important Market Trends:The global infection surveillance solution market is witnessing significant growth, driven by the rising incidence of healthcare-associated infections (HAIs) and the need for effective infection control measures. Key market drivers include the increasing adoption of advanced technologies such as artificial intelligence (AI) and big data analytics for real-time surveillance and outbreak detection. Additionally, government regulations and initiatives to promote patient safety and improve healthcare outcomes are fueling demand for infection surveillance solutions.Emerging opportunities in the market include the integration of wearable devices and IoT sensors for continuous patient monitoring and early infection detection. The growing focus on personalized medicine and precision healthcare is also creating new avenues for market growth. Remote patient monitoring and telemedicine services are expected to drive the adoption of infection surveillance solutions in home healthcare settings.Recent trends in the market include the rise of cloud-based surveillance platforms, which offer scalability, cost efficiency, and improved accessibility. The use of AI and machine learning algorithms is enhancing the accuracy and efficiency of infection detection and prediction. Furthermore, the integration of electronic health records (EHR) systems with infection surveillance solutions is facilitating seamless data sharing and comprehensive analysis.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Infection Surveillance Solution Market Drivers
Increasing Prevalence of Healthcare-Associated Infections
Global Infection Surveillance Solution Market: Propelled by Rising Prevalence of Healthcare-Associated Infections. Healthcare-associated infections pose a notable threat to patient safety, which results in elevated morbidity, mortality, and healthcare costs. Furthermore, the presence of multidrug-resistant microorganisms exacerbates the challenges of infection control. Infection surveillance solutions play a vital role in the identification, monitoring, and prevention of HAIs.Furthermore, the provision of real-time data on the rates of infection allows healthcare providers to introduce targeted interventions and enhance patient outcomes. Given the rising prevalence of HAIs and the need for efficient measures of infection prevention, the global infection surveillance solution market is growing. In accordance with a report by MarketWatch, the market is expected to reach USD 2.4 billion by 2032, growing at a CAGR of 6.41%.The key forces driving the growth of the market are the increasing occurrence of HAIs, Growing application of electronic health records by healthcare workers, Rising recognition of the significance of measures of infection prevention and control, Regulations introduced by governments that require infection surveillance, The technological advancement of infection surveillance solutions The increasing incidence of HAIs is the main factor contributing to the growth of the market.In fact, the performance of healthcare facilities across the globe is being increasingly scrutinized as these institutions face growing pressure to reduce rates of infection and enhance patient safety. Infection surveillance solutions allow for the acquisition of critical insights into the patterns and trends in the development of infections, thus enabling viable approaches to the prevention and control of infections. Global Infection Surveillance Solution Market Industry, Healthcare-Associated Infections, Infection Prevention, Patient Safety.
Technological Advancements
Artificial intelligence (AI), machine learning (ML), and data analytics are increasingly being incorporated into infection surveillance solutions, enhancing their capabilities and effectiveness. These technologies enable real-time monitoring, automated data analysis, and predictive modeling, providing healthcare providers with actionable insights to prevent and control infections. AI and ML algorithms can analyze large volumes of data to identify patterns and trends, predict outbreaks, and recommend targeted interventions. These technologies can also be used to monitor patient data, identify individuals at risk of infection, and trigger alerts for early detection and response. Data analytics provides valuable insights into infection rates, transmission patterns, and the effectiveness of prevention measures, enabling healthcare providers to make informed decisions and improve patient outcomes. The integration of advanced technologies is transforming infection surveillance solutions, making them more efficient, accurate, and user-friendly. As technology continues to evolve, the global infection surveillance solution market is expected to witness significant growth in the coming years.
Government Regulations and Initiatives
The governments are implementing regulations and taking initiatives for improving Health Care Associated Infection or HCAI prevention and control in health services through the use of infection surveillance solutions.The regulations are compulsory as they require the healthcare industry to use infection surveillance solutions for monitoring and reporting the rate of infection, detecting outbreaks, and initiating targeted interventions. Government regulatory and initiative-based factors are fuelling the global infection surveillance solution market. Governments and public health institutes are joining hands with health care providers, research institutes, and manufacturers of these systems in the development and implementation of useful infection surveillance systems.They are also raising awareness among people on infection surveillance in public and private places. All these factors drive the market for infection surveillance solutions.
Infection Surveillance Solution Market Segment Insights:
Infection Surveillance Solution Market Deployment Insights
The Infection Surveillance Solution Market is segmented by deployment type into cloud-based and on-premises. The cloud-based segment is expected to dominate the market over the forecast period owing to its scalability, cost-efficiency, and ease of access. However, the on-premises segment is expected to hold a significant market share as it provides more control over data. The cloud-based deployment model has been gaining popularity among healthcare providers. One of the main advantages of cloud-based solutions is their cost-efficiency. Healthcare providers pay only for the infrastructure that they use.Cloud-based solutions are highly scalable, allowing healthcare providers to adjust their infrastructure to their changing requirements. Furthermore, they are also easily accessible. They can be accessed from any location with an internet connection. On the other hand, the on-premises deployment model offers more control and security over the data. With on-premises solutions, healthcare providers have complete control over their data, and they can implement security measures to protect it. On the other hand, they also require more time and resources to manage.The growth of the market can be attributed to increasing prevalence of healthcare-acquired infections, adoption of electronic health records, and the need to control and prevent infections with real-time data.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Infection Surveillance Solution Market Application Insights
The application segment of the Global Infection Surveillance Solution Market is categorized into healthcare-associated infections (HAIs), antimicrobial resistance surveillance, and vaccine effectiveness monitoring. Among these, the HAI segment held the largest market share in 2023 and is projected to maintain its dominance throughout the forecast period. The increasing prevalence of HAIs, particularly in healthcare settings, has fueled the demand for infection surveillance solutions to prevent and control the spread of infections. The growing awareness of the importance of HAIs surveillance has led to the implementation of stringent regulations and guidelines by healthcare organizations worldwide.The antimicrobial resistance surveillance segment is expected to witness significant growth over the forecast period due to the rising concerns about the emergence of antimicrobial-resistant pathogens. The increasing use of antibiotics has contributed to the development of antimicrobial resistance, posing a significant threat to public health. Infection surveillance solutions play a crucial role in monitoring antimicrobial resistance patterns and implementing appropriate antibiotic stewardship programs. The vaccine effectiveness monitoring segment is gaining traction due to the increasing demand for vaccine surveillance to assess the effectiveness of vaccination programs.The COVID-19 pandemic has highlighted the importance of vaccine effectiveness monitoring to evaluate the performance of vaccines and make informed decisions regarding vaccination strategies. Infection surveillance solutions provide real-time data on vaccine effectiveness, enabling healthcare providers to track the impact of vaccination programs and identify areas for improvement.
Infection Surveillance Solution Market Data Source Insights
The Global Infection Surveillance Solution Market is segmented by data sources into electronic health records (EHRs), laboratory information systems (LISs), and patient portals. The EHRs segment is expected to account for the largest share of the market in 2023 due to the increasing adoption of EHRs by healthcare providers. The LISs segment is expected to grow at the fastest rate during the forecast period due to the increasing need for accurate and timely laboratory data for infection surveillance. The patient portals segment is expected to account for a small share of the market in 2023 but is expected to grow at a significant rate during the forecast period due to the increasing use of patient portals by patients to access their health information.In 2023, the EHRs segment is expected to account for approximately 60% of the Global Infection Surveillance Solution Market revenue. The LISs segment is expected to account for approximately 25% of the market revenue, and the patient portals segment is expected to account for approximately 15% of the market revenue. By 2032, the EHRs segment is expected to account for approximately 55% of the market revenue, the LISs segment is expected to account for approximately 30% of the market revenue, and the patient portals segment is expected to account for approximately 20% of the market revenue.The growth of the Global Infection Surveillance Solution Market is being driven by a number of factors, including the increasing prevalence of infectious diseases, the need for improved infection prevention and control practices, and the adoption of new technologies. The market is expected to continue to grow in the coming years as the need for effective infection surveillance solutions continues to increase.
Infection Surveillance Solution Market Type of Infection Insights
Type of Infection The global infection surveillance solution market is segmented by type of infection into bacterial infections, viral infections, and fungal infections. Among these segments, bacterial infections held the largest market share in 2023 and are expected to maintain their dominance throughout the forecast period. The high prevalence of bacterial infections, such as pneumonia, sepsis, and urinary tract infections, is a major factor driving the growth of this segment. Viral infections are the second-largest segment, with a significant market share.The increasing incidence of viral infections, such as influenza, COVID-19, and HIV, is contributing to the growth of this segment. Fungal infections are the smallest segment, but they are expected to witness the fastest growth during the forecast period. The rising prevalence of fungal infections, such as candidiasis and aspergillosis, is driving the growth of this segment.
Infection Surveillance Solution Market Regional Insights
The regional segmentation of the Global Infection Surveillance Solution Market offers valuable insights into the market's geographical distribution and growth dynamics. North America is expected to dominate the market with a significant share due to the presence of advanced healthcare infrastructure, high healthcare expenditure, and stringent infection control regulations. Europe is projected to follow closely, driven by increasing healthcare investments and a growing focus on patient safety. The Asia-Pacific region is anticipated to exhibit substantial growth potential due to rising healthcare awareness, expanding healthcare facilities, and government initiatives to improve infection surveillance systems.South America and the Middle East and Africa (MEA) regions are expected to contribute a smaller share but are witnessing increasing adoption of infection surveillance solutions due to improving healthcare infrastructure and government efforts to combat healthcare-associated infections.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Infection Surveillance Solution Market Key Players And Competitive Insights:
Major players in Infection Surveillance Solution Market industry are continuously focusing on developing advanced solutions to meet the evolving needs of healthcare providers and patients. Leading Infection Surveillance Solution Market players are investing in research and development to enhance the capabilities of their solutions, such as improving data analytics, machine learning algorithms, and user interfaces. The competitive landscape is characterized by a mix of established players and emerging companies, each offering unique strengths and capabilities. The industry is witnessing strategic partnerships, acquisitions, and collaborations to expand market reach and gain a competitive edge.A leading company in the Infection Surveillance Solution Market is BD, a global medical technology company. BD offers a comprehensive suite of infection surveillance solutions, including the BD EpiCenter, a cloud-based platform that provides real-time data and analytics for infection prevention and control. BD's solutions are designed to help healthcare providers identify, track, and prevent infections, improve patient safety, and reduce healthcare costs. BD has a strong market presence and a wide customer base, and it is continuously investing in innovation to maintain its leadership position.A notable competitor in the Infection Surveillance Solution Market is Optum, a leading health services and technology company. Optum offers a range of infection surveillance solutions, including the Optum Insight Infection Surveillance Solution, which provides real-time data and analytics for infection prevention and control. Optum's solutions are designed to help healthcare providers improve patient safety, reduce healthcare costs, and comply with regulatory requirements. Optum has a strong focus on data analytics and technology innovation, and it is continuously expanding its offerings to meet the needs of the healthcare industry.
Key Companies in the Infection Surveillance Solution Market Include:
- GE Healthcare
- eClinicalWorks LLC
- Oracle Corporation
- Siemens Healthineers AG
- NextGen Healthcare
- Cerner Corporation
- Wolters Kluwer Health
- IBM Corporation
- Athenahealth, Inc.
- MEDITECH
- McKesson Corporation
- Epic Systems Corporation
- SAP SE
- Allscripts Healthcare, LLC
- Greenway Health
Infection Surveillance Solution Market Industry Developments
The global infection surveillance solution market size was valued at USD 1.37 billion in 2023 and is projected to reach USD 2.4 billion by 2032, exhibiting a CAGR of 6.41% during the forecast period. The market growth is attributed to the increasing prevalence of infectious diseases, rising demand for real-time surveillance, and technological advancements in infection surveillance systems.Recent news developments include the launch of new infection surveillance solutions by key players such as BD (Becton, Dickinson and Company), BioMérieux, and Thermo Fisher Scientific. These solutions offer advanced features such as automated data collection, real-time monitoring, and predictive analytics, which are driving market growth. Moreover, government initiatives and collaborations between healthcare providers and technology companies are further propelling the adoption of infection surveillance solutions.
Infection Surveillance Solution Market Segmentation Insights
Infection Surveillance Solution Market Deployment Outlook
Infection Surveillance Solution Market Application Outlook
- Healthcare-associated infections (HAIs)
- Antimicrobial resistance surveillance
- Vaccine effectiveness monitoring
Infection Surveillance Solution Market Data Source Outlook
- Electronic health records (EHRs)
- Laboratory information systems (LISs)
- Patient portals
Infection Surveillance Solution Market Type of Infection Outlook
- Bacterial infections
- Viral infections
- Fungal infections
Infection Surveillance Solution Market Regional Outlook
- North America
- Europe
- South America
- Asia Pacific
- Middle East and Africa
| Report Attribute/Metric |
Details |
| Market Size 2023 |
0.73 (USD Billion) |
| Market Size 2024 |
0.80 (USD Billion) |
| Market Size 2032 |
1.64 (USD Billion) |
| Compound Annual Growth Rate (CAGR) |
9.44% (2024 - 2032) |
| Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year |
2023 |
| Market Forecast Period |
2024 - 2032 |
| Historical Data |
2019 - 2023 |
| Market Forecast Units |
USD Billion |
| Key Companies Profiled |
GE Healthcare, eClinicalWorks LLC, Oracle Corporation, Siemens Healthiness AG, NextGen Healthcare, Cerner Corporation, Wolters Kluwer Health, IBM Corporation, Athenahealth, Inc., MEDITECH, McKesson Corporation, Epic Systems Corporation, SAP SE, Allscripts Healthcare, LLC, Greenway Health |
| Segments Covered |
Deployment, Application, Data Source, Type of Infection, Regional |
| Key Market Opportunities |
Advanced analytics AI-driven insights Telemedicine integration Personalized patient engagement Cloud-based solutions |
| Key Market Dynamics |
Rising healthcare-associated infections Increasing prevalence of antimicrobial resistance Growing adoption of advanced technologies Government initiatives for infection control Expanding hospital networks. |
| Countries Covered |
North America, Europe, APAC, South America, MEA |
Frequently Asked Questions (FAQ) :
The Global Infection Surveillance Solution Market is expected to reach a valuation of 1.37 USD Billion in 2023.
The Global Infection Surveillance Solution Market is projected to grow at a CAGR of 6.41% from 2024 to 2032.
North America is expected to hold the largest market share in the Global Infection Surveillance Solution Market, owing to the presence of a well-developed healthcare infrastructure and a high prevalence of healthcare-associated infections.
The hospital segment is expected to drive the growth of the Global Infection Surveillance Solution Market due to the increasing number of hospitalizations and the need to prevent and control infections in healthcare settings.
Some of the key competitors in the Global Infection Surveillance Solution Market include Becton, Dickinson and Company, 3M, BioMérieux SA, and Cardinal Health.
Some of the key trends driving the growth of the Global Infection Surveillance Solution Market include the increasing prevalence of healthcare-associated infections, the growing demand for real-time infection surveillance data, and the increasing adoption of cloud-based infection surveillance solutions.
Some of the challenges facing the growth of the Global Infection Surveillance Solution Market include the lack of standardization in infection surveillance data, the high cost of implementing infection surveillance solutions, and the shortage of qualified healthcare professionals to manage infection surveillance programs.
Some of the opportunities for growth in the Global Infection Surveillance Solution Market include the development of new and innovative infection surveillance technologies, the expansion of infection surveillance programs into new healthcare settings, and the growing demand for remote infection surveillance solutions.
The Global Infection Surveillance Solution Market is expected to reach a valuation of 2.4 USD Billion by 2032.
Some of the key factors that will influence the growth of the Global Infection Surveillance Solution Market in the coming years include the increasing prevalence of healthcare-associated infections, the growing adoption of cloud-based infection surveillance solutions, and the increasing demand for real-time infection surveillance data.
